HOME >> BIOLOGY >> NEWS
Emory scientists receive NIH MIDAS grant for computer modeling of infectious diseases

Emory University scientists have received a five-year grant for more than $3 million to participate in a new National Institutes of Health (NIH) initiative to develop powerful computer modeling techniques to analyze and respond to infectious disease outbreaks. The MIDAS study (Models of Infectious Disease Agent Study) will harness the nation's computing skills to enhance our ability to respond to both disease epidemics, such as SARS, and to bioterrorism. The Emory research team, in the Department of Biostatistics of the Rollins School of Public Health, includes principal investigator Ira Longini, Jr., PhD, professor of biostatistics, M. Elizabeth Halloran, MD, DSc, professor of biostatistics, and their colleagues Azhar Nizam, MS, senior associate of biostatistics and Rustom Antia, PhD, associate professor of biology in Emory College.

The MIDAS initiative is sponsored by the National Institute of General Medical Sciences (NIGMS), which awarded a total of four research grants totaling more than $28 million over five years. Three of the grants will support the creation of mathematical models to study various aspects of infectious disease epidemics and community responses, and a fourth award funds researchers who will develop a central database to organize information from the other three groups. It also supports the development of user-friendly computer modeling tools for the broader scientific community, policy makers and public health officials to use to simulate epidemics and response strategies. "MIDAS will play a key role in the NIH biodefense plan," said Elias A. Zerhouni, MD., NIH director. "The computer models created through this initiative will help us determine the best strategies to detect, control and prevent the spread of disease."

MIDAS will bring together interdisciplinary teams of scientists with expertise ranging from mathematics and computer science to epidemiology, genetics, and public health. The network of MIDAS scientists wil
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
7-May-2004


Page: 1 2 3

Related biology news :

1. Emory researchers map structure of anti-cancer molecule
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Emory researchers develop model to track the evolution of emerging infectious diseases
4. Emory scientists use enzymes to enhance regeneration of damaged peripheral nerves in mice
5. Emory scientists track down immune sentinel cells with gene gun
6. Emory researchers discover novel mechanism of how anthrax impairs immunity
7. Emory scientists find anti-tumor compounds in magnolia cones
8. Emorys CancerQuest wins top Web award from Scientific American
9. Emory University researchers uncover novel self-assembly of Alzheimers amyloid fibrils
10. Emory Vaccine Research Center study identifies specific gene required for long-term immunity
11. Emory to receive more than $6.5 million to study environmental risk factors for Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2019)... ... November 25, 2019 , ... Though the forecast for ... more than 55 million travelers expected to hit the roads and the skies. It’s ... it’s weight in truffle oil will offer a simple design, mouth-watering pictures of food, ...
(Date:11/27/2019)... MONTREAL (PRWEB) , ... November 27, 2019 , ... ... features a sleek hand-held device, equipped with surface electromyography (sEMG) sensors that measure ... ensure the activation of the specific muscles being targeted for treatment. Both patient ...
(Date:11/19/2019)... , ... November 19, 2019 , ... Project Lifeline ... Chain Drug Stores (NACDS) Foundation to address substance use disorder (SUD) – ... Two individuals who have led to the program’s effectiveness in preventing and treating opioid ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... Fla. (PRWEB) , ... December 18, 2019 , ... Tune ... of Advancements, hosted by Ted Danson. Check local listings for more information on this ... innovations in augmented reality are helping to simplify complex system to increase the efficiency, ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... Inc. has received FDA 510(k) clearance for its latest CAPERE® Thrombectomy System ... data suggests the CAPERE® offers great benefits for first-in-line treatment for nonsurgical ...
(Date:12/4/2019)... ... 03, 2019 , ... Absolute Antibody Ltd. , an ... the Recombinant Antibody Network (RAN), a consortium of three expert centers at the ... common goal to generate recombinant antibodies at a proteome-wide scale. Under the new ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new study released today ... reduce and even reverse fibrosis (scar tissue) buildup – also improves the range of ... of Medicine, was conducted on mice. , The tumor-destroying capabilities of radiation therapy ...
Breaking Biology Technology:
Cached News: